Mass General Brigham continues an exciting and transformative journey to create the best academic health system in the world. After careful consideration and collaboration, it has been decided to integrate two of the finest divisions of Cardiac Surgery and Vascular and Endovascular Surgery at Brigham and Women’s Hospital and Massachusetts General Hospital into unified Mass General Brigham divisions. This decision was made with the utmost consideration for both institutions’ patients, trainees and research missions. By joining forces, the goal is to elevate the quality of care provided, enhance all training programs and further the groundbreaking research being done.
Matthew Eagleton, MD
Chief, Division of Vascular and Endovascular Surgery, MGB
Co-Director, Fireman Vascular Center
Robert R. Linton Professor of Surgery, Harvard Medical School
Dr. Eagleton is the Robert R. Linton Professor of Surgery at Harvard Medical School. Since his arrival at Massachusetts General Hospital in 2018 as chief of the Division of Vascular and Endovascular Surgery and co-director of the Fireman Vascular Center, he has built a collaborative and innovative multidisciplinary team that provides care to patients with vascular disease regionally, nationally and internationally. In addition, as co-director of the Mass General Thoracic Aortic Center, he has developed clinical, educational and research programs in collaboration with a multidisciplinary group of specialists focused on patients with aortic disease. Reflecting the high regard in which he is held by his peers, Dr. Eagleton has been selected as president elect of the Society for Vascular Surgery (SVS). He will transition to the role of president in the spring of 2024.
Dr. Eagleton received his medical degree in 1994 and completed his general surgery residency in 2000, both at the University of Rochester. In 2002, he completed specialty training in vascular surgery at the University of Michigan and obtained advanced training in endovascular procedures at the Cleveland Clinic. Prior to his current role at Mass General, Dr. Eagleton was professor of surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and served as vice chairman of the Department of Vascular Surgery and as director of Vascular Surgery at the Cleveland Clinic Aortic Center. In addition, he held the role of education program director, overseeing the training for the Cleveland Clinic Integrated Residency (0+5) and Independent Fellowship (5+2) training programs in vascular surgery, as well as their endovascular mini fellowship and aortic fellowship.
Dr. Eagleton conducts innovative clinical research applying fenestrated and branched aortic endograft technology to treat complex aortic disease through a physician-sponsored investigational device exemption trial, and his clinical practice follows suit. In addition, he has been involved in numerous endograft clinical trials serving as an investigator, national principal investigator and advisor. He collaborates with a team of physicians, both locally and internationally, to better understand how to provide safer, more durable treatment options to patients with life-threatening aortic disease. He has served as director of several innovative biomedical research companies aimed at developing improved treatment options for patients with vascular disease.
Collaboration and teamwork have been a central theme in Dr. Eagleton’s efforts. He views this opportunity to bring the teams at Brigham and Women’s Hospital and Massachusetts General Hospital together as a privilege to expand the opportunities for collaboration across the system with the aim of improving the care we can provide our patients with vascular disease.
